26 Dec 2021

Hello reader!

Changes to the model portfolio are being made effective from 27 Dec 2021 and can be viewed in the Members Area.

The new COVID-19 variant is disruptive but will likely not derail economic growth. The Federal Reserve's tightening of quantitative easing and the institution's greater sensitivity to inflation are near-term risks over the next six months, but should eventually prolong the expansion. The market has stabilized since learning about a shift in the Federal Reserve's stance. Smaller companies are even more sensitive to economic growth and what's good for the US economy is good for small caps. The growth should remain strong in the first half of next year. Although it's hard to generalize about the entire small cap segment, some pockets should perform relatively better.

The Prudent Small Cap model portfolio will have three new positions and be 90% invested, up from 60% earlier. The new positions will continue to be sized close to the level of recent additions instead of at a higher level. Thus, the Cash balance in the model portfolio is being divided by 4.25 to determine the size of a single position. That's how it will be reflected in the Additional Information spreadsheet.

For any questions, kindly contact us at support@GraycellAdvisors.com.

Sincerely,
Graycell Advisors

Graycell Advisors, and its affiliates, officers, employees, families, and all other related parties, collectively referred to as ‘Graycell’ and/or ‘we,’ is a publisher of financial information, such as the Prudent Biotech and Smallcap newsletters. Historical performance figures provided are hypothetical and unaudited, and based on our proprietary analysis and system performance, back-tested over an extended period of time. The performance results obtained are intended for illustrative purposes only. Past performance is not indicative of future results, which may vary. All stock and related investments have a degree of risk, which can result in a significant or total loss. In addition, smallcap segment is characterized by much higher risk and volatility than the general stock market. The Information contained herein does not constitute a personal recommendation or takes into account the particular investment objectives, financial situations, or needs of individual investors. If you decide to invest in any of the stocks of the companies mentioned in the newsletters, samples, alerts, etc., sent to you or available on our websites, you can and may lose some or all of your investment. You alone are responsible for your own investment decisions. We are not liable nor do we assume any responsibility for losses incurred as a result of any information provided or not provided or not made available in a timely manner, herein or on our website or using any other medium.  We also cannot guarantee the accuracy and completeness of any information furnished by us. Graycell is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. We may or may not already have existing positions in the stocks mentioned in our reports. Our models are proprietary and/or licensed and can be changed or revised based on our discretion at any time without any notification. Subscribers and investors should always conduct their own due diligence with any potential investment and consider obtaining professional advice before making an investment decision.